Compare GE Aerospace (GE) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE Aerospace vs BIO-TECHNE Corp — how do they compare? GE Aerospace trades at $368.06 (market cap $380.47B), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: GE Aerospace is far larger — about 33.8× BIO-TECHNE Corp's market cap, and GE Aerospace pays the higher dividend (0.51%). Which is the better fit depends on your goals.
| GE | TECH | |
|---|---|---|
Market Cap | $380.47B | $11.24B |
Sector | Industrials | Health |
52-Week High | $381.22 | $72.29 |
52-Week Low | $265.93 | $43.31 |
Enterprise Value | $390.29B | $11.32B |
Dividend Yield | 0.51% | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE trades at $370.08, down 1.19% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $45.86B in 2025, with net income margin at 17.72%, while valuation ratios like P/E of 43.64 appear elevated. Recent news highlights robust aerospace demand and defense contract wins, supporting positive sentiment.
Outlook is favorable due to strong order growth and analyst consensus, but risks include high debt levels and rich valuations. The stock offers upside to the $414.11 price target, yet investors should monitor execution amid competitive pressures.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE Aerospace
General Electric Company is a globally diversified technology and financial services company. The Company's products and services include aircraft engines, power generation, water processing, and household appliances to medical imaging, business and consumer financing, and industrial products.
Read more on GE →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
